Skip to content

The Effect of tDCS Combined With TMS on Cognitive Impairment and Motor Function After Stroke

The Effect of Transcranial Electrical Stimulation Combined With Transcranial Magnetic Stimulation on Cognitive Impairment and Motor Function After Stroke

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07573475
Enrollment
24
Registered
2026-05-07
Start date
2026-05-01
Completion date
2027-05-01
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognition Disorders, Stroke

Brief summary

This clinical trial aims to investigate whether transcranial electrical stimulation (tDCS) combined with transcranial magnetic stimulation(TMS) has an impact on the cognitive and motor functions of stroke patients, and to evaluate the safety of this protocol. The main objective is to answer the following question: Can electromagnetic combined stimulation of the left Dorsolateral prefrontal lobe(DLPFC) improve the performance of working memory, motor function and cognitively motor dual tasks in stroke patients? What is its mechanism of action? Participants will undergo a combined real or sham electromagnetic stimulation of 20 minutes of tDCS and 40 seconds of TMS once a day for 7 days. Researchers will compare the effects of real stimulation with sham stimulation to see if the real stimulation can bring better results to patients. Clinical evaluations (cognitive and motor scales) and functional Near-Infrared Spectroscopy(fNIRS) were conducted before and after stimulation to record relevant brain activities

Interventions

OTHERsham tDCS

sham 20 minutes of tDCS once a day for 7 days

40 seconds of real TMS once a day for 7 days

OTHERsham TMS

40 seconds of sham TMS once a day for 7 days

BEHAVIORALoccupational therapy

occupational therapy 1 hour a day for 7 days

real 20 minutes of tDCS once a day for 7 days

Sponsors

Ke Dong, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Meeting the diagnostic criteria for hemorrhagic or ischemic stroke in the Chinese Guidelines for the Prevention and Treatment of Cerebrovascular Diseases(2nd edition), with the first onset, single hemisphere stroke, and confirmed by CT or MRI,course of diease 1-6 months; * Age ranging from 30 to 80 years old; * Native language is Mandarin or Cantonese; * Right-handed; * Diagnosed with post-stroke cognitive impairment(PSCI) by the MoCA scale; * Able to cooperate in completing the speech repetition test; * Normal hearing.

Exclusion criteria

* Currently receiving non-invasive brain stimulation treatment; * Lesions involving the left DLPFC brain regions; * History of epilepsy, mental illness,or other neurological or mental disorders; * Any contraindications for transcranial electrical stimulation.

Design outcomes

Primary

MeasureTime frameDescription
Verbal fluency test(VFT)accuracy rateBaseline and 7-daysVFT task record accuracy rate
functional connectivity during Verbal fluency test(VFT)Baseline and 7-daysVFT task with fNIRS to record Oxy-Hb concentration
functional connectivity during n-back taskBaseline and 7-daysn-back task with fNIRS to record Oxy-Hb concentration
Verbal fluency test(VFT)reaction timeBaseline and 7-daysVFT task record reaction time
n-back task accuracy rateBaseline and 7-daysn-back task record accuracy rate
n-back task reaction timeBaseline and 7-daysn-back task record reaction time

Secondary

MeasureTime frameDescription
Montreal Cognitive Assessment(MoCA)Baseline and 7-daysMoCA scale(score 0-30, the higher score means the better function)
isokinetic muscle strength testBaseline and 7-daysisokinetic muscle strength test of knee

Countries

China

Contacts

CONTACTJingting Li
lijt53@mail.sysu.edu.cn+86 13560365827
CONTACTHanjun Liu
lhanjun@mail.sysu.edu.cn+86 15920175118

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026